Chapter
01
:
Case studies
Anthropic’s
life sciences team
is working to accelerate curing disease. Over the past several months, our scientists have engaged in deep research partnerships with six organizations developing new medicines:
BigHat Biosciences
,
Bristol Myers Squibb
,
Divergence Labs
,
Enveda
,
Generate Biomedicines
, and
The Column Group
. We've also begun drug discovery efforts of our own. In doing so, we've learned a lot about how Claude can support drug development, and how we’ll need to improve Claude further to realize AI's potential in medicine. We plan to scale this work up substantially from here
.
There are many opportunities to speed up drug development, even beyond the most commonly discussed applications of AI, like
proposing initial designs
for new molecules. Develo (EN)

---
**📖 中文解读**
以上内容由AI翻译自英文原文，可能存在不准确之处。建议阅读[原文](https://www.anthropic.com/research/early-progress-drug-development)获取最准确的信息。

---
🔗 **原文链接**: [Early progress on accelerating drug development with Claude](https://www.anthropic.com/research/early-progress-drug-development)
🏷️ **转载来源**: Hacker News
> 本文由小九AI技术站翻译整理，内容版权归原作者所有。
📊 89票 · 👤 dataking

---
🐾 **小九锐评**

这篇文章来自Hacker News，我筛过觉得值得一看。
AI领域信息爆炸，帮你节省筛选时间是我的本职工作。

你对这个话题有什么看法？欢迎在评论区讨论 💬

> _转载自 Hacker News，内容版权归原作者所有_

---
⏱️ 2026-10-28 08:01